Lineage Cell Therapeutics In shares owned by Newbridge Financial Services Group
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Newbridge Financial Services Group
from 13F filings
Historical chart of Newbridge Financial Services Group investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Newbridge Financial Services Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Newbridge Financial Services Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $7 | 5 | 1.40 |
| 2023-12-31 | $5 | 5 | 1.00 |
| 2023-09-30 | $6 | 5 | 1.20 |
| 2023-06-30 | $7 | 5 | 1.40 |
| 2023-03-31 | $8 | 5 | 1.60 |
| 2022-12-31 | $6 | 5 | 1.20 |
| 2022-09-30 | $0 | 5 | 0.00 |
| 2022-06-30 | $0 | 5 | 0.00 |
More positions owned by Newbridge Financial Services Group
View all positions for Newbridge Financial Services Group